Muco Stop
Natural health product licensed in Canada
- Licence holder
- Enzymedica Inc.
- NPN or DIN-HM
- 80039311
- Status
- Active licence
- Licence date
- 30 January 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Poly(1-4-a-D-galacturonide)glycanohydrolase Source : Aspergillus niger | 2.4 mg | Not calculated |
| Poly(1-4-a-D-galacturonide)glycanohydrolase Source : Aspergillus niger | 60 Endo-PG | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger | 1 mg | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger | 30 FCC HCU | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum | 4 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma longibrachiatum | 550 XU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger | 3 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum | 3 mg | Not calculated |
| 4-alpha-D-Glucane glucanohydrolase Source : Aspergillus flavus var. oryzae | 140 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae | 51 mg | Not calculated |
| Protéase Source : Aspergillus niger | 51 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger | 50 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger | 50 FCC AGU | Not calculated |
| Oryzine Source : Aspergillus melleus | 30 mg | Not calculated |
| Oryzine Source : Aspergillus melleus | 10,500 FCC PC | Not calculated |
| Protéase bactérien Source : Bacillus subtilis | 5 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropyl methylcellulose, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzymes. Alpha-galactosidase helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains). Seaprose S breaks down mucus and helps to reduce symptoms such as pain, quantity of secretion, and stuffy nose/nasal congestion from ear, nose, and throat infections.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80039311
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.